Merck and Ridgeback announcd data for investigational LAGEVRIO (molnupiravir) from Phase 3 MOVe-OUT study
On Jun. 7, 2022, Merck and Ridgeback Biotherapeutics announced the Annals of Internal Medicine had published additional data…
On Jun. 7, 2022, Merck and Ridgeback Biotherapeutics announced the Annals of Internal Medicine had published additional data…
On Jun. 6, 2022, the U.S. Department of Agriculture (USDA) reported that the largest, highest quality analysis of…
On Jun. 6, 2022, Pfizer further strengthened its commitment to United States manufacturing with a $120 million investment…
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…
On Jun. 2, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the presence…
On Jun. 2, 2022, Moderna announced an agreement with the European Commission (EC) to amend their originally agreed…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On Jun. 2, 2022, the U.S. National Institutes of Health announced that a large randomized, placebo-controlled clinical trial…
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
On May 31, 2022, Novavax announced the initiation of its Phase 3 strain change trial to determine if…
On May 31, 2022, Ultima Genomics emerged from stealth business mode with a new high-throughput, low-cost sequencing platform…
On May 30, 2022, The Centre for Health Protection (CHP) of the Department of Health received notification from…
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
On May 26, 2022, RELIEF THERAPEUTICS announced that the parent company, NRx Pharmaceuticals, of its collaboration partner with…
On May 26, 2022, BD (Becton, Dickinson) announced a new high-throughput molecular diagnostic combination test for SARS-CoV-2 and…
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMixᆴ Modular…
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 25, 2022, the Health and Human Servicesagency (HHS) announced the formal establishment of the Advanced Research…
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
On May 23, 2022, Jaguar Health announced the launch of Canine Cancer: Take C.H.A.R.G.E. (Canine Health And ReGistry…
On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…
On May 21, 2022, the WHO announced that since May 13, 2022, cases of monkeypox had been reported…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On May 19, 2022, the U.S. National Institutes of Health (NIH) announced that people who reported in a…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…